BR112014009225A8 - uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes - Google Patents

uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes

Info

Publication number
BR112014009225A8
BR112014009225A8 BR112014009225A BR112014009225A BR112014009225A8 BR 112014009225 A8 BR112014009225 A8 BR 112014009225A8 BR 112014009225 A BR112014009225 A BR 112014009225A BR 112014009225 A BR112014009225 A BR 112014009225A BR 112014009225 A8 BR112014009225 A8 BR 112014009225A8
Authority
BR
Brazil
Prior art keywords
whey protein
protein micelles
young children
obesity
diabetes
Prior art date
Application number
BR112014009225A
Other languages
English (en)
Other versions
BR112014009225A2 (pt
Inventor
Mace Catherine
Pouteau Etienne
Jean Rene Bovetto Lionel
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47045036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014009225(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112014009225A2 publication Critical patent/BR112014009225A2/pt
Publication of BR112014009225A8 publication Critical patent/BR112014009225A8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00Whey; Whey preparations
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018Hydrolysed proteins; Derivatives thereof from animals from milk
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Abstract

resumo patente de invenção: "uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes". a presente invenção refere-se às micelas de proteína de soro de leite para utilização no tratamento e/ou na prevenção de uma doença associada a um aumento na secreção de insulina e/ou concentração de igf- 1 no plasma em um criança pequena em risco de desenvolvimento de obesidade ou diabetes. a presente invenção também refere-se a uma composição nutricional para crianças pequenas compreendendo as micelas de proteína de soro de leite. além disso, a presente invenção refere-se a uma utilização não terapêutica de uma composição nutricional para crianças pequenas, compreendendo as micelas de proteína de soro de leite.
BR112014009225A 2011-10-21 2012-10-19 uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes BR112014009225A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11186141.5A EP2583562A1 (en) 2011-10-21 2011-10-21 Use of whey protein micelles for infants at risk of obesity or diabetes
PCT/EP2012/070718 WO2013057233A1 (en) 2011-10-21 2012-10-19 Use of whey protein micelles for infants at risk of obesity or diabetes

Publications (2)

Publication Number Publication Date
BR112014009225A2 BR112014009225A2 (pt) 2017-06-13
BR112014009225A8 true BR112014009225A8 (pt) 2017-06-20

Family

ID=47045036

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014009225A BR112014009225A8 (pt) 2011-10-21 2012-10-19 uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes

Country Status (10)

Country Link
US (1) US10028978B2 (pt)
EP (2) EP2583562A1 (pt)
CN (1) CN103906440B (pt)
AU (1) AU2012324887B2 (pt)
BR (1) BR112014009225A8 (pt)
CL (1) CL2014000865A1 (pt)
ES (1) ES2643892T3 (pt)
MX (1) MX350866B (pt)
RU (1) RU2616525C2 (pt)
WO (1) WO2013057233A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
WO2015065193A1 (en) 2013-11-01 2015-05-07 N.V. Nutricia Lipid composition for improving body composition during catch-up growth
CN105764355A (zh) * 2013-11-25 2016-07-13 雀巢产品技术援助有限公司 乳基营养组合物与胃部不适
MX2016006577A (es) * 2013-11-29 2016-08-03 Nestec Sa Uso de composiciones nutritivas que tienen una cantidad baja de proteina.
AU2014356485A1 (en) * 2013-11-29 2016-03-03 Nestec S.A. Infant nutrition for improvement in insulin sensitivity later in life
WO2015085555A1 (en) * 2013-12-12 2015-06-18 Nestec S.A. Array of age-tailored infant formula with optimum protein content and lactose content
EP3574771B1 (en) 2015-10-15 2022-11-16 N.V. Nutricia Infant formula with special lipid architecture for promoting healthy growth
WO2018104512A1 (en) 2016-12-09 2018-06-14 N.V. Nutricia Nutritional composition for improving cell membranes
CN109982584B (zh) 2017-01-11 2023-05-02 雀巢产品有限公司 具有包含乳清蛋白质胶束的乳清蛋白质和酪蛋白源的热灭菌高蛋白质勺舀型营养组合物
WO2018159546A1 (ja) * 2017-03-03 2018-09-07 森永乳業株式会社 Glp-1分泌促進剤及び組成物
EP4356961A2 (en) * 2019-06-13 2024-04-24 Société des Produits Nestlé S.A. Use of whey protein micelles for controlling postprandial glucose response
JP2023500674A (ja) * 2019-11-08 2023-01-10 アボット・ラボラトリーズ ウシ乳汁単離粉末状エクソソーム、栄養組成物および方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2683492B2 (ja) * 1993-09-07 1997-11-26 雪印乳業株式会社 ミセル状ホエー蛋白質、その溶液、その粉末およびミセル状ホエー蛋白質の製造法
MXPA00002122A (es) * 1997-08-29 2003-06-09 Ricex Company Inc Un metodo para tratar la diabetes, la hiperglucemia y la hipoglucemia.
DE69904257T2 (de) * 1999-01-20 2003-04-17 Nutricia Nv Säuglingsnährpräparat
DE19906379B4 (de) * 1999-02-16 2006-05-18 Huss, Manfred Herstellung eines aggregierten Molkenproteinprodukts
GB0302929D0 (en) * 2003-02-10 2003-03-12 Inst Of Child Health Nutrient composition
WO2005002600A2 (en) * 2003-06-30 2005-01-13 Nestec S.A. Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus
WO2005021589A1 (en) * 2003-08-30 2005-03-10 Nestec S.A. Acid soluble proteins from micellar casein
MY153295A (en) * 2004-09-29 2015-01-29 Nestec Sa Nanoparticulated whey proteins
MX2007007898A (es) 2004-12-27 2007-08-20 Nestec Sa Uso de formula para lactantes con contenido de proteina reducido.
AU2006266546B2 (en) * 2005-07-01 2012-01-12 N.V. Nutricia Infant nutrition with hydrolised proteins
EP2305049A1 (en) 2005-12-23 2011-04-06 N.V. Nutricia Infant nutritional compositions for preventing obesity
PL1839492T3 (pl) * 2006-03-27 2012-02-29 Nestec Sa Micele białka serwatkowego
ATE472317T1 (de) * 2006-03-27 2010-07-15 Nestec Sa Kosmetische verwendung von molkeproteinmizellen
EP1932437A1 (en) 2006-12-15 2008-06-18 Nestec S.A. Infant formula
CN101438738A (zh) * 2007-11-23 2009-05-27 内蒙古蒙牛乳业(集团)股份有限公司 一种降血糖的酸奶及其生产方法
SG185344A1 (en) 2008-10-17 2012-11-29 Nestec Sa Whey protein compositions, methods and uses
JP2013521779A (ja) * 2010-03-12 2013-06-13 ネステク ソシエテ アノニム 栄養素の風味をマスクするための組成物及び該組成物の調製方法

Also Published As

Publication number Publication date
AU2012324887B2 (en) 2015-10-29
US20140287056A1 (en) 2014-09-25
AU2012324887A1 (en) 2014-04-03
CN103906440A (zh) 2014-07-02
MX350866B (es) 2017-09-22
WO2013057233A1 (en) 2013-04-25
RU2014120428A (ru) 2015-11-27
EP2779846B1 (en) 2017-09-06
CL2014000865A1 (es) 2014-08-18
US10028978B2 (en) 2018-07-24
EP2779846A1 (en) 2014-09-24
MX2014004802A (es) 2015-12-03
CN103906440B (zh) 2016-09-21
BR112014009225A2 (pt) 2017-06-13
ES2643892T3 (es) 2017-11-27
RU2616525C2 (ru) 2017-04-17
EP2583562A1 (en) 2013-04-24

Similar Documents

Publication Publication Date Title
BR112014009225A8 (pt) uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes
IN2014KN02830A (pt)
PH12016500959A1 (en) Use of nutritional compositions having a low protein amount
MX2015008114A (es) Derivados de exendina-4.
BR112014010275A2 (pt) formulações para tratamento de diabetes
BR112014004726A2 (pt) combinação farmacêutica para uso no controle glicêmico em pacientes de diabetes tipo 2
MY196432A (en) Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health
MX2013009948A (es) Composiciones de insulina y cromo para el tratamiento y prevencion de diabetes, hipoglucemia y alteraciones relacionadas.
EA201591529A1 (ru) Лечение детского дефицита гормона роста человеческими аналогами гормона роста
BR112013029269A8 (pt) combinação farmacêutica para uso na indução de perda de peso em pacientes com diabetes tipo 2 e/ou para prevenir o ganho de peso em pacientes com diabetes tipo 2
BR112013029256A8 (pt) combinação farmacêutica para uso no tratamento de pacientes com diabetes tipo 2
RU2015122497A (ru) Содержащие лактоферрин питательные композиции на основе молока и их применение
MY175195A (en) Nutritional compositions
BR112015011931A2 (pt) composições nutricionais contendo treonato de magnésio e usos das mesmas
BR112014012460A2 (pt) proteínas recombinantes e seus usos terapêuticos
BR112014008512A2 (pt) composições nutricionais de caseína-soro de leite parcialmente hidrolizadas para redução do início de alergias
UA117480C2 (uk) Лікування цукрового діабету за допомогою складу інсуліну тривалої дії
BR112015006656A8 (pt) composições e métodos para o tratamento de insuficiência cardíaca em pacientes diabéticos
EA201491369A1 (ru) Способ лечения сахарного диабета при помощи негликозилированного аполипопротеина a-iv
BR112014000182A2 (pt) mascaramento do amargor
BR112013024791A2 (pt) aclidínio para uso na melhoria da qualidade do sono em pacientes com sintomas respiratórios, composição farmacêutica compreendendo o mesmo e seus usos.
EA201791611A1 (ru) Лечение пациентов детского возраста с сахарным диабетом 2 типа с помощью ликсисенатида
BR112014009414A2 (pt) uso de micelas de proteína de soro do leite para melhorar o perfil de insulina em pacientes diabéti-cos
MX2017003659A (es) Composicion nutricional con bajo contenido de acidos grasos de cadena media en proporciones especificas y sus usos.
PH12015500683A1 (en) Formula fortifier

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 35/20 (2006.01), A23C 21/00 (2006.01), A23L 3

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2484 DE 14-08-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B350 Update of information on the portal [chapter 15.35 patent gazette]